Rheumatoid Arthritis Recruiting Phase 1 Trials for Rituximab (DB00073)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03161457A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid ArthritisTreatment
NCT03061838Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera®Treatment